EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Endolysins and Their Potential in Combating Bacterial Multidrug Resistance

Olga I Guliy, Olga A Karavaeva

Frontiers in Bioscience-Elite · 2026-06-01 · 18 (2)

DOI: 10.31083/fbe44070 ↗

At a glance

Übersichtsarbeit in Frontiers in Bioscience-Elite, published online on 2026-06-01. Written by Olga I Guliy and 1 co-authors. Institution: Institute of Biochemistry and Physiology of Plants and Microorganisms - Subdivision of the Federal State Budgetary Research Institution Saratov Feder…. Major MEDLINE topics: Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Endopeptidases. 180 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministry of Science and Higher Education of the Russian Federation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Since the discovery of penicillin in 1928, more than a thousand antibiotics have been introduced into medical practice. Initially, the introduction of antibiotics revolutionized the treatment of infectious diseases. However, as antibiotics have been used repeatedly, scientists and clinicians have observed serious adverse consequences, most notably the emergence of bacterial resistance to antimicrobial agents. Of particular concern are multidrug-resistant pathogens, which are resistant to multiple antibiotic classes. As of 2024, antibiotic-resistant bacteria are directly responsible for approximately 1.27 million deaths worldwide. Thus, in response, possible new antibacterial agents are under investigation, including bacteriophages and the associated bacteriolytic enzymes. According to the World Health Organization (WHO), phage-based drugs are leading nonclassical antibiotics currently in clinical trials. Meanwhile, endolysins, as bacteriolytic phage enzymes, have emerged as promising antibacterial agents. This study reviews the key achievements and mechanisms of action of bacteriophage endolysins against bacterial infections, including biofilms, and discusses the therapeutic potential of endolysins in combating antibiotic resistance. Finally, the combined use of endolysins with other biomolecules and the application of artificial intelligence to address antimicrobial-resistant infections are also discussed.

Subjects

MeSH terms (MEDLINE)

Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsEndopeptidasesBacteriophagesBiofilmsHumansBacteria

Author keywords

bacteriophagesendolysinsinfectionmultidrug resistancetherapy

Substances

endolysinAnti-Bacterial AgentsEndopeptidases

Authors and institutions

  • Institute of Biochemistry and Physiology of Plants and Microorganisms - Subdivision of the Federal State Budgetary Research Institution Saratov Federal Scientific Centre of the Russian Academy of Sciences (IBPPM RAS), 4…

Funding

  • Ministry of Science and Higher Education of the Russian Federation

Cite

APA

Guliy, O. I., & Karavaeva, O. A. (2026). Endolysins and Their Potential in Combating Bacterial Multidrug Resistance. Frontiers in Bioscience-Elite, 18(2). https://doi.org/10.31083/fbe44070

Vancouver

Guliy OI, Karavaeva OA. Endolysins and Their Potential in Combating Bacterial Multidrug Resistance. Frontiers in Bioscience-Elite. 2026;18(2). doi:10.31083/fbe44070

BibTeX
@article{Guliy2026,
  author = {Guliy, Olga I and Karavaeva, Olga A},
  title = {Endolysins and Their Potential in Combating Bacterial Multidrug Resistance},
  journal = {Frontiers in Bioscience-Elite},
  year = {2026},
  volume = {18},
  number = {2},
  doi = {10.31083/fbe44070}
}
Start for free →